Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(17%)
Results Posted
100%(4 trials)

Phase Distribution

Ph phase_3
4
67%
Ph phase_4
1
17%
Ph not_applicable
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
4(66.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Other(1)

Detailed Status

Completed4
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 34 (66.7%)
Phase 41 (16.7%)
N/A1 (16.7%)

Trials by Status

completed467%
recruiting117%
unknown117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DRUG
Total Trials
6